ASAP3 disrupts ASAP1-ARHGAP12 to inhibit RhoA and yes-associated protein/transcriptional coactivator with PDZ-binding motif, suppressing gastric cancer progression

doi:10.4251/wjgo.v18.i8.117876

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 8

This Article

(16)

(14)

(0)

(15)

(159)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Aug 15, 2026; 18(8): 117876
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.117876

Full Size Figure Download Figure

Figure 9 Correlation between ASAP3/ASAP1/ARHGAP12 and clinicopathologic features using bioinformatics. A: Correlation between ASAP3/ASAP1/ARHGAP12 and age; B: Correlation between ASAP3/ASAP1/ARHGAP12 and gender; C: Correlation between ASAP3/ASAP1/ARHGAP12 and tumor node metastasis stage; D: Correlation between ASAP3/ASAP1/ARHGAP12 and tumor size (mm); E: Correlation between ASAP3/ASAP1/ARHGAP12 and patient overall survival. TNM: Tumor node metastasis; FPKM: Fragments per kilobase of transcript per million mapped reads.

Citation: Huang XB, Deng Y, Gong SY, Yu M, Cai H. ASAP3 disrupts ASAP1-ARHGAP12 to inhibit RhoA and yes-associated protein/transcriptional coactivator with PDZ-binding motif, suppressing gastric cancer progression. World J Gastrointest Oncol 2026; 18(8): 117876
URL: https://www.wjgnet.com/1948-5204/full/v18/i8/117876.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i8.117876

Huang XB, Deng Y, Gong SY, Yu M, Cai H. ASAP3 disrupts ASAP1-ARHGAP12 to inhibit RhoA and yes-associated protein/transcriptional coactivator with PDZ-binding motif, suppressing gastric cancer progression. World J Gastrointest Oncol 2026; 18(8): 117876 [DOI: 10.4251/wjgo.v18.i8.117876]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.